BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15587839)

  • 1. Prevalence of rubella antibody in pregnant women in Ibadan, Nigeria.
    Bamgboye AE; Afolabi KA; Esumeh FI; Enweani IB
    West Afr J Med; 2004; 23(3):245-8. PubMed ID: 15587839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of rubella-IgG antibody in women of childbearing age in Lagos, Nigeria.
    Onyenekwe CC; Kehinde-Agbeyangi TA; Ofor US; Arinola OG
    West Afr J Med; 2000; 19(1):23-6. PubMed ID: 10821082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic survey of specific rubella virus IgM in the sera of pregnant women in Makurdi, Benue State, Nigeria.
    Pennap G; Amauche G; Ajoge H; Gabadi S; Agwale S; Forbi J
    Afr J Reprod Health; 2009 Jun; 13(2):69-73. PubMed ID: 20690250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal rubella serosurvey in Maputo, Mozambique.
    Barreto J; Sacramento I; Robertson SE; Langa J; de Gourville E; Wolfson L; Schoub BD
    Trop Med Int Health; 2006 Apr; 11(4):559-64. PubMed ID: 16553940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rubella virus infection and associated factors among pregnant women attending the antenatal care clinics of public hospitals in Hawassa City, Southern Ethiopia: a cross-sectional study.
    Tamirat B; Hussen S; Shimelis T
    BMJ Open; 2017 Oct; 7(10):e016824. PubMed ID: 28982820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence survey of rubella infection in pregnancy at the University of Benin Teaching Hospital, Benin City, Nigeria.
    Onakewhor JU; Chiwuzie J
    Niger J Clin Pract; 2011; 14(2):140-5. PubMed ID: 21860127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological Evaluation of Rubella Virus Infection among Pregnant Women in Ibadan, Nigeria.
    Adewumi OM; Olayinka OA; Olusola BA; Faleye TO; Sule WF; Adesina O
    J Immunoassay Immunochem; 2015; 36(6):613-21. PubMed ID: 25774539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
    Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
    East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sero-prevalence of rubella among pregnant women in India, 2017.
    Muliyil DE; Singh P; Jois SK; Otiv S; Suri V; Varma V; Abraham AM; Raut C; Gupta M; Singh MP; Viswanathan R; Naik S; Nag V; Benakappa A; Bavdekar A; Sapkal G; Singh K; Gupta N; Verma S; Santhanam S; Mishra S; Bhatnagar A; Prasad GRV; Kolekar J; Raj N; Sabarinathan R; Sachdeva RK; George S; Chaudhary S; Verghese VP; Jagtap V; Bharadwaj M; Murhekar M
    Vaccine; 2018 Dec; 36(52):7909-7912. PubMed ID: 30448333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rubella serology in pregnant women attending health centres of Tehran University of Medical Sciences.
    Majlessi F; Batebi A; Shariat M; Rahimi A; Azad TM
    East Mediterr Health J; 2008; 14(3):590-4. PubMed ID: 18720623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk factors of exposure to rubella among pregnant women in Zaria 2013.
    Gubio AB; Mamman AI; Abdul M; Olayinka AT
    Pan Afr Med J; 2019; 32(Suppl 1):4. PubMed ID: 30949283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of rubella antibodies among pregnant females in Sri Lanka.
    Palihawadana P; Wickremasinghe AR; Perera J
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):398-404. PubMed ID: 12971571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubella virus infections and immune status among pregnant women before the introduction of rubella vaccine in Amhara Regional State, Ethiopia.
    Wondimeneh Y; Tiruneh M; Ferede G; Abera B; Workineh M; Birhanie M; Tessema B
    Int J Infect Dis; 2018 Nov; 76():14-22. PubMed ID: 30165188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM and IgG antibodies specific to rubella in child bearing women.
    Ahmed MU
    J Pak Med Assoc; 1992 May; 42(5):121-2. PubMed ID: 1507389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey.
    Uyar Y; Balci A; Akcali A; Cabar C
    New Microbiol; 2008 Oct; 31(4):451-5. PubMed ID: 19123299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of rubella-specific IgG antibody in non-immunized pregnant women in Maiduguri, north eastern Nigeria.
    Bukbuk DN; el Nafaty AU; Obed JY
    Cent Eur J Public Health; 2002 Jun; 10(1-2):21-3. PubMed ID: 12096678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and risk factors for rubella infection in pregnant women attending a tertiary hospital in Kano-Nigeria.
    Zahradeen SU; Muhammad ID; Adamou N; Rabiu A; Yusuf MA; Shuaibu SAD; Ibrahim G
    Pan Afr Med J; 2023; 46():97. PubMed ID: 38405097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of rubella virus immunity of immunized and non-immunized pregnant women visiting Kogi State University Teaching Hospital, Anyigba, North Central Nigeria.
    O Okolo ML; Omatola CA; Ogbonnaya O; Odama LE; Bello KE; Idache BM; Ekuma OU
    J Immunoassay Immunochem; 2020 Jul; 41(4):709-717. PubMed ID: 32188320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella seroprevalence and demographic feature analysis in pregnant women from Southern Pakistan.
    Khan A; Rahman H; Noushin R; Anjum SI; Saad F; Ullah K
    J Pak Med Assoc; 2019 Aug; 69(8):959-963. PubMed ID: 31431775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubella virus,
    Mirambo MM; Mshana SE; Groß U
    Afr Health Sci; 2019 Jun; 19(2):1858-1865. PubMed ID: 31656468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.